• Home
  • Contact Us
  • Privacy & Policy
Tuesday, May 24, 2022
Finances Advise
No Result
View All Result
  • Home
  • Business
  • Commodities
  • Crypto News
    • Block chain
    • Bitcoin
    • Ethereum
    • Litecoin
  • Finance
    • Financial Advisors
    • Personal Finance
    • Market Insider
  • Forex
  • Investing
  • Stocks
  • ICOs
  • Trading
  • Home
  • Business
  • Commodities
  • Crypto News
    • Block chain
    • Bitcoin
    • Ethereum
    • Litecoin
  • Finance
    • Financial Advisors
    • Personal Finance
    • Market Insider
  • Forex
  • Investing
  • Stocks
  • ICOs
  • Trading
No Result
View All Result
Finances Advise
No Result
View All Result
Home Market Insider

Nike, Hims & Hers Health, FedEx & more

by admin
March 22, 2021
in Market Insider
0
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter


A pedestrian walks past American multinational sport clothing brand, Nike store and its logo seen in Hong Kong.

Budrul Chukrut | SOPA Images | LightRocket | Getty Images

Check out the companies making headlines after the bell on Thursday:

FedEx – Shares of the delivery service ticked up 3.6% after the company announced fiscal third-quarter results that topped analyst expectations. FedEx posted earnings per share of $3.47 on revenue of $21.51 billion. Analysts polled by Refinitiv expected earnings per share of $3.23 on revenue of $19.97 billion. The company said its strong results were driven in part by an “unprecedented” holiday shipping season.

Hims & Hers Health – The telehealth company’s stock slid 2.6% after Hims & Hers posted its fourth-quarter results. Hims reported a loss of 7 cents per share on revenue of $41.5 million. There were too few estimates to compare to analyst predictions.

Nike – Nike’s stock fell 2.4% after the company posted mixed fiscal third-quarter results as inventory delays and store closures impacted sales. Nike logged earnings per share of 90 cents on revenue of $10.36 billion. Analysts surveyed by Refinitiv expected earnings per share of 76 cents on revenue of $11.02 billion.

Sarepta Therapeutics – Sarepta shares popped 8.4% after the biopharmaceutical company released new trial results for its limb-girdle muscular dystrophy treatment. Sarepta said “participants demonstrated continued improvements from baseline across all functional measures.”



Source link

Tags: FedExhealthHimsNike
  • Trending
  • Comments
  • Latest

A 48-year market vet warns that the Fed will be forced to tighten policy ‘way sooner’ than investors anticipate as inflation continues to soar — triggering a stock market crash of up to 80%

August 28, 2021
27-year-old UG graduate now millionaire proposes to girlfriend on b’day in video

27-year-old UG graduate now millionaire proposes to girlfriend on b’day in video

August 9, 2021

‘It’s begging to be destroyed’: A stock trader who says he made more than $100,000 shorting the market during the 2008 crash just bet against the S&P 500 — and warns there’s a ‘fair chance’ stocks are about to drop 25%

September 11, 2021

Stocks tanked in the first quarter, and new research shows there should be a reversal by the end of June

April 15, 2022
5 Important Rules for Forex Trading – The Video Ink

5 Important Rules for Forex Trading – The Video Ink

0

Uber Hacking: Customers Not at Risk of Financial Crime, Says Minister

0

Black Friday Merchants Look to Extend Moment of Retail Optimism

0

Hotshot Snapchat Founders Face a Dilemma: Lie Low or Live Large?

0
5 Important Rules for Forex Trading – The Video Ink

5 Important Rules for Forex Trading – The Video Ink

May 24, 2022

Stocks Are Falling Amid Recession Fears

May 24, 2022

Best Buy, Abercrombie & Fitch, Snap and more

May 24, 2022

Let’s Dissect The “Follow The Money #1” Documentary, Pt. 1- Salvadoran Confusion | Bitcoinist.com

May 24, 2022

Recent News

5 Important Rules for Forex Trading – The Video Ink

5 Important Rules for Forex Trading – The Video Ink

May 24, 2022

Stocks Are Falling Amid Recession Fears

May 24, 2022

Categories

  • Bitcoin
  • Block chain
  • Business
  • Commodities
  • Ethereum
  • Financial Advisors
  • Forex
  • Investing
  • Litecoin
  • Market Insider
  • Personal Finance
  • Stocks

Site Navigation

  • Home
  • Contact Us
  • Privacy & Policy

We bring the Best and latest Crypto News

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Business
  • Commodities
  • Crypto News
    • Block chain
    • Bitcoin
    • Ethereum
    • Litecoin
  • Finance
    • Financial Advisors
    • Personal Finance
    • Market Insider
  • Forex
  • Investing
  • Stocks
  • ICOs
  • Trading

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.